NASDAQ · NIVFW
NewGenIvf Group Limited Warrants financials
$0.01930.00%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Gross margin | — | — |
| Operating income | — | — |
| Net income | — | — |
| Net margin | — | — |
| Diluted EPS | — | — |
| EBITDA | $0.00 | $0.00 |
| Operating cash flow | — | — |
| Free cash flow | — | — |
| Diluted shares | 1.1M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $758.6K | $457.7K |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $4.4M | $2.4M |
| Total assets | $32.7M | $3.6M |
| Total liabilities | $6.7M | $5.1M |
| Shareholders' equity | $26.0M | -$1.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology